Molecular point-of-care (POC) testing for sexually transmitted infections (STIs) in emergency departments costs 43% more than centralized laboratory testing, according to a cost-modeling study published in The American Journal of Emergency Medicine.
While POC testing shortens patient wait times, these gains do not currently offset the higher direct expenditures.
- Cost vs. Speed: POC tests provide results during an emergency department visit, but the materials and labor costs remain significantly higher than traditional batch processing in a central lab.
- Throughput Dynamics: Faster results can reduce the time a patient spends in the emergency room, but hospitals only realize financial gains if that vacated time is filled by other revenue-generating patients.
- Societal Impact: While POC testing reduces the costs associated with the overtreatment or undertreatment of infections, these savings are not sufficient to close the gap created by higher per-test prices.
Researchers led by Anisha Paul-Ledesma of the Johns Hopkins Bloomberg School of Public Health constructed a cost model based on a prospective, quasi-experimental study at the Johns Hopkins Hospital emergency department. They followed a hypothetical cohort of 1,000 women over one year to compare molecular POC testing against centralized laboratory testing (CLT) for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis.
The analysis revealed that POC testing cost $16,502 more than CLT for the cohort. Although POC testing successfully reduced post-discharge notification costs—dropping from $1,571 to $187—the total hospital cost remained 37.7% higher when using rapid molecular platforms. From a societal perspective, which accounts for downstream costs like repeat emergency department visits and treatment errors, the financial disparity persisted at $77,297 for POC versus $52,955 for CLT.
The primary advantage of POC testing lies in its ability to expedite clinical decision-making. The study found that POC testing reduced the median length of stay in the emergency department by 43 minutes. Over a cohort of 1,000 women, this equates to 717 hours of saved room time.
The authors said that if an emergency department operates at capacity, these freed hours could theoretically generate $788,700 in new revenue, assuming a rate of approximately $1,100 per hour. However, this relies on the assumption that the facility can immediately utilize that time for other patients. For emergency departments that are not consistently at full capacity, the financial incentive to adopt higher-cost POC testing is diminished.
| Cost Metric | Centralized Lab (CLT) | Point-of-Care (POC) |
|---|---|---|
| Total Hospital Cost (per 1000) | CLT costs | POC costs |
| Overtreatment Costs | $2,613 | $1,023 |
| Undertreatment Costs | $1,417 | $424 |
| Post-discharge Notification | $1,571 | $187 |
The underlying research was supported by Visby Medical, the manufacturer of the point-of-care test utilized in the study, which provided both funding and test kits to Johns Hopkins University. One author also received salary support through National Institutes of Health grants.
Readers should note that the study relied on a relatively small sample size from a single academic center in a region with high STI prevalence, which may limit the generalizability of the findings to different healthcare settings.
The model assumed 100% sensitivity and specificity for both testing methods. In clinical practice, molecular diagnostic accuracy can vary based on specimen quality and the specific genetic targets of the assay. The study was published in the October 29, 2026, issue of The American Journal of Emergency Medicine.
- Paul-Ledesma A, et al. The American Journal of Emergency Medicine. 2026.